PubMed Health⌕ Search

Biomedical subjects

N A Probatova

Publications and source records attributed to N A Probatova.

15 recordsLinked to original sources
PubMed1992

[Epithelial membrane antigen in lymphosarcoma cells (immunomorphologic study)].

11 cases of different types of lymphosarcoma of T- and B-nature are studied immunohistochemically by means of antibodies against epithelial membrane antigen (EMA), including new Soviet monoclonal antibodies ICO-25 to this antigen, common leucocytic antigen, vimentin and cytokeratin. The phenomenon of the EMA including ICO-25 binding to the cells of some lymphosarcomas is confirmed. This indicates that the use of only this "epithelial differentiation marker" in not sufficient for the differentiation between lymphosarcoma and poorly differentiated carcinoma. Variability of lymphosarcoma cells staining by vimentin antibodies is shown, other limitations of the immunohistochemical examination of lymphoma are discussed. The conclusion is made of the necessity to use the spectrum of the above antibodies when differentiating between lymphosarcoma and poorly differentiated carcinoma.

Antigens, Differentiation↗
PubMed1991

[The treatment procedure in olfactory (esthesioneurogenic) tumors].

In 1968-1988, eleven cases of olfactory neurogenic tumors were seen at The All-Union Center for Oncology Research, Moscow which made up 9.5% of the total of nasal cavity cancers. Morphologically, esthesioneurocytoma was diagnosed in two patients whereas esthesioneuroblastoma--in nine. Four patients received combined therapy while seven--chemotherapy and radiation. Progression of the disease was registered in 7 out of 11 patients: in 3 of 4 cases receiving combination treatment and in 4 out of 7 those treated conservatively. Four cases died within 7-29 months while 7 remain alive: two patients at 18 and 156 months following combined therapy and 5--at 18, 18, 24, 84 and 132 months after chemoradiation treatment. Radiation alone proved the best therapeutic option. Surgery is justified in cases with residual tumor as second-line procedure.

Adolescent↗
PubMed1990

[The morphological diagnosis of malignant non-Hodgkin's lymphomas (lymphosarcomas)].

On the basis of morphoimmunological correlates certain criteria have been elaborated helpful in diagnosis of non-Hodgkin's malignant lymphomas (NML) of both B- and T-cell origin, and this was reflected in the modified Kiel's classification. The group of T-cell NML has considerably increased. T-cell origin of Lennert's lymphoma and angioimmunoblastic lymphadenopathy has been proven. Morphological substrate of NML from peripheral T-lymphocytes became more precise. The tumours, depending on the predominant cells, are subdivided into small cell (T-zones and pleomorphic lymphoma of small cells), mixed cell (pleomorphic lymphoma of medium-size and large cells) and large cell lymphoma (immunoblastic and large cell anaplastic Ki-I+). Criticism of T-NML systematization is due to the lack of definite cytological criteria because of the extreme morphological heterogeneity of peripheral T-lymphocytes and different interpretation of the clinical course of the established morphological variants. Among B-cell lymphomas the problem of the so-called intermediate lymphocytic lymphoma (ILL) and its variety--a mantle-zone lymphoma as well as monocytoid B-cell lymphoma is discussed in the literature. It is established in immunological testing that the cells of ILL possess a phenotype of cells of the primary follicles and those of the mantle-zone of the secondary follicles while the cells of the monocytoid B-cell NML have a peculiar unique phenotype similar to that of cells in the marginal zone of the spleen follicles.

Humans↗
PubMed1989

Two different anti-erythroid monoclonal antibodies in immunodiagnosis of human leukemias: a comparative study.

To date, only anti-glycophorin-A monoclonal antibodies (MAbs) have been widely used as anti-erythroid probes in the diagnosis of leukemias. We have examined blood, bone-marrow and lymph-node samples from 474 patients, adults and children, with different hemopoietic malignancies, using a panel of MAbs including 2 anti-erythroid MAbs directed to glycophorin-A and an antigen of erythroblasts, Ag-Eb. MAb HAE9 directed against a human epitope of Ag-Eb has earlier been shown to be highly specific for immature erythroid cells. Of all the patients, 2.7% demonstrated glycophorin-A expression on blast cells, while anti-Ag-Eb MAb HAE9 reacted positively with cells from 6.0% of patients. Samples from 31 of 474 (6.5%) patients expressed one or both erythroid markers. Our results indicate that MAb HAE9 may be useful, in combination with anti-glycophorin-A MAbs, as an anti-erythroid probe for immunophenotyping human leukemias.

Adult↗
PubMed1989

[The clinical characteristics of hematosarcoma with primary skin involvement].

As many as 90 patients suffering from hematosarcomas associated with primary skin lesions were examined. This patients' group did not include patients with mycosis fungoides or with Sezary's syndrome. The clinical picture, ways and stages of the spreading of skin hematosarcomas were reviewed. Damage to the internal organs outstripped lymph nodes injuries in 1/3 of the patients. Half of the patients followed up until their death died at the height of acute leukemia. The survival appeared relatively high: the median period turned out to be 51 months, whereas 33% of the patients survived for 10 and more years. The survival was influenced by the sex and age of the patients as well as by the histological disease variant.

Adolescent↗
PubMed1976

[Dermatofibrosarcoma protuberans].

Observations were conducted on 26 patients with protruding dermatofibrosarcoma of the skin. Histological and histochemical characteristics, as well as the mitotic regimen of these tumours, were investigated. Protruding dermatofibrosarcoma is a fibroblastic tumour characterized by a slow growth, usually a big size, persistent multiple reoccurrence, late metastases into the lymphatic nodes and lungs. No regularities concerning periods and frequency of developing of reoccurrences could be established. Clinico-anatomical collations failed to show correlation between the mitotic activity of dermatofibrosarcomas and the degree of their malignancy and rate of growth of the tumour.

Adult↗
PubMed1975

Blastomogenic activity of p-hydroxyphenyllactic acid in mice.

Blastomogenic activity of p-hydroxyphenyllactic acid was established by prolonged s.c. administration into C57BL/6 and CC57BR mice. Phenyllactic acid was also tested and was not blastomogenic under the same conditions. The preparations in aqueous solutions were injected into the dorsal region twice weekly in 1.5-mg doses. The total dose per mouse was 42 mg p-hydroxyphenyllactic acid or 50 mg phenyllactic acid. The resorptive character and many forms of blastomogenic activity of p-hydroxphenyllactic acid were shown. It induced neoplasms of varied histogenesis (leukemias, adenomas, hepatomas, and tumors of the vascular tissue),including benign and malignant tumors and precancerous conditions of the urniary bladder.

Adenoma↗